AAL

Sarepta Therapeutics Stock Eyes Best Day in 3 Years on FDA Reversal

It would take shorts 11 days to cover their bearish bets

Managing Editor
Dec 13, 2019 at 11:31 AM
facebook X logo linkedin


Drug maker Sarepta Therapeutics Inc (NASDAQ:SRPT) is soaring this morning, up 33% at $132.50. The company's Duchenne Muscular Dystrophy (DMD) treatment was approved by the Food and Drug Administration (FDA), a surprise considering the FDA rejected the drug back in August. Sarepta had repealed the FDA's decision, leading to today's shocking win. Also of note, Needham hiked its price target to $182 from $170.

Today's impressive bull gap is not only filling the equity's aforementioned August sell-off, but it now has SRPT pacing toward its largest one-day jump since September 2016. In the current quarter alone, Sarepta stock has added 76%.

Short interest dropped just over 5% during the past two reporting periods, but now accounts for a whopping 20.8% of the stock's total available float. At Sarepta's average pace of daily trading, it would take short sellers 11 days to buy back their bearish bets.

Digging deeper, now looks like an attractive time for those wanting to speculate on SRPT's next move with options. The drug concern's Schaeffer's Volatility Index (SVI) of 51% sits higher than just 16% of readings from the past year.

Lastly, the stock’s Schaeffer's put/call open interest ratio (SOIR) of 0.39 ranks 11 percentage points from an annual low, showing there is an unusual call-skew in the front three-months' series. In fact, the January 2020 120- and 110-strike calls are holding the two most popular open interest positions this afternoon.

 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.